Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential Diagnosis of Tumor-like Brain Lesions.
Perez Giraldo GS, Singer L, Cao T, Jamshidi P, Dixit K, Kontzialis M, Castellani R, Pytel P, Anadani N, Bevan CJ, Grebenciucova E, Balabanov R, Cohen BA, Graham EL. Perez Giraldo GS, et al. Among authors: dixit k. Neurol Clin Pract. 2023 Oct;13(5):e200182. doi: 10.1212/CPJ.0000000000200182. Epub 2023 Aug 30. Neurol Clin Pract. 2023. PMID: 37664132 Review.
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
McCord M, Jamshidi P, Thirunavu V, Santana-Santos L, Vormittag-Nocito E, Dittman D, Parker S, Baczkowski J, Jennings L, Walshon J, McCortney K, Galbraith K, Zhang H, Lukas RV, Stupp R, Dixit K, Kumthekar P, Heimberger AB, Snuderl M, Horbinski C. McCord M, et al. Among authors: dixit k. Acta Neuropathol Commun. 2023 Nov 2;11(1):175. doi: 10.1186/s40478-023-01680-0. Acta Neuropathol Commun. 2023. PMID: 37919784 Free PMC article.
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.
Driscoll RK, Lyne SB, Voce DJ, Maraka S, Gondi V, Chmura SJ, Dixit KS, Kumthekar PU, Karrison TG, Pytel P, Collins JM, Stupp R, Merrell RT, Lukas RV, Yamini B. Driscoll RK, et al. Among authors: dixit ks. Neurooncol Adv. 2024 Feb 1;6(1):vdae014. doi: 10.1093/noajnl/vdae014. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38420615 Free PMC article.
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
Rogers JL, Wall T, Acquaye-Mallory AA, Boris L, Kim Y, Aldape K, Quezado MM, Butman JA, Smirniotopoulos JG, Chaudhry H, Tsien CI, Chittiboina P, Zaghloul K, Aboud O, Avgeropoulos NG, Burton EC, Cachia DM, Dixit KS, Drappatz J, Dunbar EM, Forsyth P, Komlodi-Pasztor E, Mandel J, Ozer BH, Lee EQ, Ranjan S, Lukas RV, Raygada M, Salacz ME, Smith-Cohn MA, Snyder J, Soldatos A, Theeler BJ, Widemann BC, Camphausen KA, Heiss JD, Armstrong TS, Gilbert MR, Penas-Prado M. Rogers JL, et al. Among authors: dixit ks. J Neurooncol. 2024 Apr;167(2):349-359. doi: 10.1007/s11060-024-04613-6. Epub 2024 Mar 1. J Neurooncol. 2024. PMID: 38427131 Free PMC article.
Recent advances in managing/understanding meningioma.
Shaikh N, Dixit K, Raizer J. Shaikh N, et al. Among authors: dixit k. F1000Res. 2018 Apr 24;7:F1000 Faculty Rev-490. doi: 10.12688/f1000research.13674.1. eCollection 2018. F1000Res. 2018. PMID: 29770198 Free PMC article. Review.
181 results